Spanu Pennestri, Teresa
 Distribuzione geografica
Continente #
EU - Europa 7.142
NA - Nord America 5.874
AS - Asia 2.975
SA - Sud America 477
AF - Africa 67
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.574
Nazione #
US - Stati Uniti d'America 5.811
DE - Germania 3.209
CN - Cina 1.605
SE - Svezia 841
SG - Singapore 758
IT - Italia 707
UA - Ucraina 477
BR - Brasile 427
PL - Polonia 427
FR - Francia 380
GB - Regno Unito 303
IE - Irlanda 249
FI - Finlandia 158
ID - Indonesia 153
IN - India 127
RU - Federazione Russa 123
TR - Turchia 112
AT - Austria 61
BE - Belgio 51
CA - Canada 44
HK - Hong Kong 31
IR - Iran 27
AU - Australia 26
NL - Olanda 25
VN - Vietnam 23
ES - Italia 21
JP - Giappone 21
KR - Corea 20
MA - Marocco 19
CH - Svizzera 17
CZ - Repubblica Ceca 16
PH - Filippine 16
IQ - Iraq 15
AR - Argentina 14
PK - Pakistan 10
EG - Egitto 9
MT - Malta 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
CI - Costa d'Avorio 8
EC - Ecuador 8
MX - Messico 8
VA - Santa Sede (Città del Vaticano) 8
CL - Cile 7
EU - Europa 7
GR - Grecia 7
PE - Perù 7
VE - Venezuela 7
ZA - Sudafrica 7
KZ - Kazakistan 6
MY - Malesia 6
NG - Nigeria 6
SD - Sudan 6
BD - Bangladesh 5
LT - Lituania 5
LV - Lettonia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
EE - Estonia 4
HU - Ungheria 4
KE - Kenya 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
RO - Romania 4
BG - Bulgaria 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
IL - Israele 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BO - Bolivia 2
CU - Cuba 2
CY - Cipro 2
GT - Guatemala 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
TW - Taiwan 2
YE - Yemen 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
SC - Seychelles 1
Totale 16.569
Città #
Chandler 1.083
Hangzhou 604
Ashburn 450
Singapore 443
Warsaw 364
Jacksonville 350
Ann Arbor 267
San Mateo 253
Dublin 243
Nürnberg 226
Woodbridge 216
Nanjing 213
Wilmington 200
Dearborn 176
Fairfield 175
Beijing 152
New York 151
Jakarta 150
Seattle 140
Houston 130
Boston 103
Milan 100
Izmir 97
Rome 89
Moscow 85
Lawrence 80
Cattolica 79
Marseille 76
Munich 75
The Dalles 75
Nanchang 72
Chicago 68
Los Angeles 64
Redwood City 61
Princeton 57
Cambridge 53
Helsinki 52
Kraków 51
Kunming 48
Brussels 47
São Paulo 43
Vienna 43
Bremen 42
Shenyang 42
Guangzhou 38
Mountain View 37
Boardman 36
North Bergen 34
Frankfurt am Main 33
Tianjin 32
Hefei 30
Hebei 29
Hong Kong 28
London 28
Zhengzhou 28
Jiaxing 27
Norwalk 27
Changsha 25
Redmond 24
Falls Church 22
Fremont 22
Lancaster 21
Nuremberg 21
Shanghai 19
Leawood 18
University Park 18
Simi Valley 17
Augusta 16
Rio de Janeiro 16
Seoul 16
Paris 15
Pune 15
Jinan 14
Toronto 14
Phoenix 13
San Francisco 13
Buffalo 12
Campinas 12
Costa Mesa 12
Düsseldorf 12
Ningbo 12
Ottawa 12
Kish 11
San Diego 11
Zurich 11
Brooklyn 10
Lauterbourg 10
Sydney 10
Washington 10
Auburn Hills 9
Baghdad 9
Brno 9
Fuzhou 9
Lanzhou 9
Porto Alegre 9
Abidjan 8
Andover 8
Belo Horizonte 8
Cairo 8
Charlotte 8
Totale 8.573
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 408
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit. 381
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 316
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 315
Factors associated with mortality in bacteremic patients with hematologic malignancies. 314
Factors associated with mortality in bacteremic patients with haematologic malignancies 311
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 280
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples 273
Diabetic foot infections: a comprehensive overview 258
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 243
A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry 236
Empyema caused by Prevotella bivia complicating an unusual case of spontaneous chylothorax. 226
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 223
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 207
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 204
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 196
Application of MALDI-TOF mass spectrometry in clinical diagnostic microbiology 189
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 188
Factors associated with mortality in bacteremic patients with hematologic malignancies. 179
Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples 176
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 172
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 168
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 163
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 163
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 163
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 159
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli 158
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 152
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 151
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 150
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 146
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 145
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 142
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno (TM) and VITEK (R) 2 systems with the broth microdilution method 139
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 137
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 133
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 133
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 132
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 132
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 126
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 126
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 126
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 124
Catheter-related bacteremia by Cupriavidus metallidurans 120
Pertussis in infants less than 6 months of age and household contacts, Italy April 2014 117
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli 116
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 116
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 115
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 114
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man 113
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 112
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 111
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 111
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 110
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 110
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 109
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man. 107
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 106
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 104
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 104
Compliance of clinical microbiology laboratories with recommendations for the diagnosis of bloodstream infections 104
Efficient Recovery of Candida auris and Five Other Medically Important Candida Species from Blood Cultures Containing Clinically Relevant Concentrations of Antifungal Agents 103
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 102
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 102
Ventriculitis due to Staphylococcus lugdunensis: two case reports 101
Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis 101
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 100
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 99
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 98
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study--authors' response 97
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 96
Clinical impact of pulmonary sampling site in the diagnosis of ventilator-associated pneumonia: A prospective study using bronchoscopic bronchoalveolar lavage 93
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 92
Lice, rodents, and many hopes: a rare disease in a young refugee 92
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 92
Implementation of the eazyplex(®) CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital 92
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. 90
Comparing BioFire FilmArray BCID2 and BCID panels for direct detection of bacterial pathogens and antimicrobial resistance genes from positive blood cultures 90
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy 89
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 89
Predictors of mortality among adult, old and the oldest old patients with bloodstream infections: An age comparison 89
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 88
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 88
Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles 87
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 87
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections 86
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 86
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 86
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 85
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 85
Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories 84
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 84
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates 83
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015) 82
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 82
Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1 81
Reply to Seligman 80
HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era 79
Totale 14.059
Categoria #
all - tutte 61.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 0 0 0 0 0 0 0 0 0 0 0 171
2020/20211.473 110 150 18 127 187 140 206 56 183 52 204 40
2021/20221.365 112 113 44 81 67 83 46 239 59 83 211 227
2022/20233.069 371 418 206 430 204 341 149 278 387 93 124 68
2023/20241.364 86 353 39 84 64 197 86 77 15 60 131 172
2024/20252.298 73 76 211 90 243 73 91 119 434 246 547 95
Totale 16.740